Insulin-like Growth Factors in breast cancer

Acta Oncologica

Volumn 35, Issue SUPPL. 5, 1996, Pages 19-22

  Helle, Svein I ^a   Lønning, Per E ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; DROLOXIFENE; MEGESTROL ACETATE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TAMOXIFEN;

BREAST CANCER; CANCER CELL CULTURE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; ENDOPEPTIDASES; ESTROGEN ANTAGONISTS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MEGESTROL; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, SOMATOMEDIN; SOMATOMEDINS; TAMOXIFEN; TUMOR CELLS, CULTURED;

EID: 0030499384     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869609083963     Document Type: Article

References (29)

1. Kvinnsland S, Lønning PE, Dahl O. Treatment of breast carcinoma with aminoglutethimide. Acta Radiol Oncology 1984; 23: 421-4.
2. Murray RML, Pitt P. Aminoglutethimide in tamoxifen-resistant patients. The Melbourne experience. Cancer Res (suppl.) 1982; 42: 3437s-41s.
3. Horwitz KB. Mechanisms of hormone resistance in breast cancer. Breast Cancer Res Treat 1993; 26: 119-30.
4. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Rev 1995; 16: 3-34.
5. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer 1992; 65: 311-20.
6. Karey KP, Sirbasku DA. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17B-oestradiol. Cancer Res 1988; 48: 4083-92.
7. Mathieu M, Rochefort H, Barenton B, Prebois C, Vignon F. Interactions of cathepsin-D and insulin-like growth factor II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II. Mol Endocrinol 1990; 4: 1327-35.
8. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, Cullen KJ, et al. Analysis of insulin-like growth factor I expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 1989; 3: 509-17.
9. Lee AV, Darbre P, King RJB. Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells. Mol Cell Endocrinol 1994; 99: 211-20.
10. Neuenchwander S, Roberts CT, LeRoith D. Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid. Endocrinology 1995; 136: 4298-303.
11. Arteaga CI, Osborne CK. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 1989; 49: 6237-41.
12. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, et al. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 1990; 50: 48-53.
13. Foekens JA, Portengen H, Janssen M, Klijn JGM. Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer. Cancer 1989; 63: 2139-47.
14. Peyrat J, Bonneterre J, Beuscart R, Djiane J, Demaille A. Insulin-like growth factor receptors in human breast cancer and their relation to oestradiol and progesterone receptors. Cancer Res 1988; 48: 6429-33.
15. Jammes H, Peyrat J-P, Ban E, Vilain M-O, Haour F, Djiane J, et al. Insulin-like growth factor 1 receptors in human breast tumour: Localisation and quantification by histo-autoradiographic analysis. Br J Cancer 1992; 66: 248-53.
16. Pekonen F, Nyman T, Ilvesmäki V, Partanen S. Insulin-like growth factor binding proteins in human breast cancer tissue. Cancer Res 1992; 52: 5204-7.
17. Helle SI, Lønning PE. Insulin-like growth factors in breast and prostatic cancer. Endocrine-Related Cancer 1995; 2: 152-169.
18. Peyrat JP, Bonneterre J, Hecquet B, Vennin P, Louchez MM, Fournier C, et al. Plasma Insulin-like growth factor-I (IGF-I) concentrations in human breast cancer. Eur J Cancer 1993; 29A: 492-7.
19. Bruning PF, van Doorn J, Bonfrer JMG, van Noord PAH, Korse CM, Linders TC, et al. Insulin-like growth factor binding protein 3 is decreased in early-stage operable premenopausal breast cancer. Int J Cancer 1995; 62: 266-70.
20. Davenport ML, Clemmons DR, Miles MV, Camacho-Hubner C, D'Ercole AJ, Underwood LE. Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology 1990; 127: 1278-86.
21. Blat C, Villaudy J, Binoux M. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to larger cells. J Clin Invest 1994; 93: 2286-90.
22. Holly JMP, Claffey DCP, Cwyfan-Hughes SC, Frost VJ, Yateman ME. Proteases acting on IGFBPs: their occurrence and physiological significance. Growth Reg 1993; 3: 58-61.
23. Frost VJ, Helle SI, Lønning PE, van der Stappen JWJ , Holly JMP. Effects of treatment with megestrol acetate, aminoglutethimide or formestane on insulin-like growth factor (IGF)-I and -II, IGF-binding proteins and insulin-like growth factor-binding protein -3 protease status in patients with advanced breast cancer. J Clin Endocrinol Metab 1996; 81: 2216-21.
24. Stewart AJ, Johnson MD, May FEB, Westley BR. Role of the insulin-like growth factors and the type I insulin-like growth factor receptor in the oestrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 1990; 265: 21172-8.
25. Rochefort H. Ooestrogens, proteases and breast cancer. From cell lines to clinical applications. Eur J Cancer 1994; 30A: 1583-6.
26. Kawamura I, Lacey E, Mizota T, Tsjujimoto S, Nishigaki F, Manda T, et al. The effect of droloxifene on the insulin-like growth factor-I stimulated growth of breast cancer cells. Anticancer Res 1994; 14: 427-32.
27. Lønning PE, Hall K, Aakvaag A, Lien EA. Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein 1 in breast cancer patients. Cancer Res 1992; 52: 4719-23.
28. Helle SI, Anker GB, Tally M, Hall K, Lønning PE. Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-I and IGFBP-3 in breast cancer patients. J Steroid Biochem Molec Biol 1996; 57: 167-71.
29. Lien EA, Johannessen DC, Aakvaag A, Lønning PE. Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients. J Steroid Biochem Molec Biol 1992; 41: 541-3.